Lugano, Switzerland, 23 June 2021
- Gender and race: new concepts in clinical trials
- Colorectal cancer screening and the future of chemoprevention
- Novel immuno-oncology mechanisms and approaches in GI cancers
- Rare GI cancers: updates and new clinical data
- New developments in radiation oncology
- The effetcts of drug interactions in GI oncology
- How to improve outcomes of patients with metastatic pancreatic cancer
The programme will address other topics such as advances in surgery and transplant, new diagnostic and screening techniques, new agents and treatment strategies, biomarkers for checkpoint inhibitors. (2)
The results of more than 300 studies from researchers in various parts of the world will be presented either as oral or poster presentations, and published online as a supplement of Annals of Oncology. The abstract titles can be viewed through the online programme.
- "Bowel cancer data reinforce need to reduce unnecessary antibiotic use"
Doctors and patients are being advised to reduce unnecessary antibiotic use following new data suggesting that these medicines may increase the risk of cancer of the large intestine (colon), especially in people under 50 years.
- "Poorer survival in obese colorectal cancer patients possibly linked to lower chemotherapy doses"
Obese patients with colorectal cancer receive lower cumulative relative doses of adjuvant chemotherapy than non-obese patients. Further findings showed that cumulative relative chemotherapy dose was associated with survival so may explain the poorer survival that has been seen in obese patients receiving adjuvant chemotherapy for colorectal cancer.
The WGI Congress welcomes media interested in obtaining information and reporting on cancer issues. Only through the official accreditation process with the media registration form, (3) accredited media representatives will be able to access scientific and educational sessions (live streamed and on-demand), virtual exhibition and industry satellite symposia, Congress webcasts, and embargoed material.
For further information
WGI Press Office firstname.lastname@example.org
Notes to Editors
Please make sure to use the official name of the meeting in your reports: ESMO World Congress on Gastrointestinal Cancer 2021
Official Congress Hashtag: #WorldGI2021
About the European Society for Medical Oncology (ESMO)
ESMO is the leading professional organisation for medical oncology. With more than 25,000 members representing oncology professionals from over 160 countries worldwide, ESMO is the society of reference for oncology education and information. Driven by a shared determination to secure the best possible outcomes for patients, ESMO is committed to standing by those who care about cancer through addressing the diverse needs of #ONEoncologycommunity, offering #educationforLIFE, and advocating for #accessiblecancerCARE. Visit http://www.esmo.org
About the ESMO World Congress on Gastrointestinal Cancer
The ESMO World Congress on Gastrointestinal Cancer represents the year's premier gathering of international oncology professionals, discussing the latest emerging data and new research in this rapidly advancing scientific field and dedicated to improving the lives of patients impacted by diseases of the GI tract. Visit http://www.worldgicancer.com/